FDA wants more proof COVID-19 plasma therapy works

The U.S. Food and Drug Administration (FDA) won’t authorize the use of blood plasma to treat COVID-19 patients until more data about the treatment can be reviewed, federal officials announced. Convalescent plasma (CP) therapy relies on blood plasma donations from…